.png?imageMogr2/crop/220x71/gravity/center/format/webp)
.png?imageMogr2/format/webp)
Bandage slippage is one of the most common complaints in wound care — and one of the most preventable. When a bandage loses contact with the skin, three things happen simultaneously: the wound is exposed to contamination, the dressing itself becomes a friction point, and the patient instinctively adjusts or replaces it, disrupting the healing environment. The root cause is rarely the adhesive alone. It is the substrate — the structural layer that must follow skin movement without resisting — that determines whether a bandage stays in place. Elastic nonwoven materials, specifically TPU-based constructions, are engineered to address this at the material level. This article examines the properties that matter and the specifications buyers should verify.
The Three Ways Bandages Lose Contact
Bandage failure follows three dominant mechanisms. Understanding which one applies to a given product helps narrow the material specification to the correct property set.
- Edge lift. The perimeter of the bandage peels away from the skin, typically starting at the corners. This is a curvature compliance problem: the substrate resists the skin's three-dimensional topography, creating peel stress that the adhesive cannot counter. Materials with lower flexural rigidity and multi-directional stretch reduce this stress at the edge.
- Creep separation. Under sustained tension — for example, a bandage stretched over a knee or elbow — the substrate gradually elongates and loses recovery force. The bandage loosens not because the adhesive failed, but because the substrate crept away. This is a material viscoelastic property, not an adhesive problem.
- Shear migration. The entire bandage shifts position through lateral skin movement, especially on mobile joints. The failure is at the substrate-skin interface: materials with high surface friction and conformability stay put; stiff or slippery materials migrate.
Each mechanism demands a different material response. Edge lift needs curvature compliance and low bending stiffness. Creep separation needs high elastic recovery and low stress relaxation. Shear migration needs surface friction and bulk conformability. No single number on a data sheet covers all three. Buyers must evaluate the complete property profile.
What "Grip" Means for an Elastic Nonwoven Bandage Substrate
Grip is not adhesion. In bandage design, grip describes the combined effect of:
- Surface friction — the static and dynamic coefficient of friction between the substrate and skin. Elastic nonwoven materials typically exhibit higher surface friction than films because the fiber structure creates micro-scale contact points. A static COF above 0.4 measured against a skin analog generally provides reliable positional stability.
- Conformability — the material's ability to assume the skin's local shape without generating restoring force. This is the inverse of bending stiffness. Thin elastic nonwoven constructions under 0.2 mm can conform to features like knuckles, wrist creases, and the metacarpal ridge without bridging.
- Elastic tension balance — the substrate should apply enough tension to maintain contact, but not so much that it generates peel stress at the adhesive line. The sweet spot is an elastic modulus between 0.5 and 5 MPa at working strain, which provides secure hold without compression.
An elastic nonwoven with multi-directional stretch distributes tension across all axes simultaneously, so the bandage holds in place through shape conformity rather than compressive force. This matters particularly on joints, where flexion in one direction must not generate a lever at the bandage edge in another.
Elastic Recovery Under Repeated Movement
A bandage on a finger or knee cycles through dozens of stretch-relax sequences per hour. Materials that look elastic on a single-pull test can lose recovery after repeated strain. Two measurements separate genuinely recoverable substrates from those that will loosen in wear:
- Hysteresis after 5 cycles. The energy loss between the loading and unloading curve per cycle. This is tested by cycling the material to a defined strain (typically 50% of its elongation at break) and measuring the area between the stress-strain curves. Low hysteresis indicates that most of the work input is returned as recovery force.
- Permanent set. Measured as percentage residual elongation after cycling. A material stretched to 50% and released should return to within 5% of its original length after 5 cycles. Values above 10% permanent set produce visible sag after several hours.
- Stress relaxation. When held at constant strain, the force decays over time. This is the creep separation mechanism at the material level. Materials with relaxation below 15% after 4 hours at physiological temperature maintain bandage position.
Testing standards such as ASTM D3107 and ISO 20932 provide frameworks for elastic recovery testing, but they were developed for woven and knitted textiles. For elastic nonwoven films and composites, the test parameters — target strain, hold time, recovery time, and cycle count — should reflect the intended wear duration and range of motion for the specific bandage application.
Flexibility That Adapts to Joint Curvature
Flexibility and stretch are not synonymous. A material can have 400% elongation but still resist bending around a tight radius because of its bulk stiffness. For bandages applied to fingers, elbows, knees, and ankles, flexibility means the ability to bend without buckling, and the measurement that matters is bending length.
Bending length, tested per ASTM D1388 or ISO 9073-7, is the length of material that bends under its own weight to a defined angle. For medical bandage substrates, bending lengths below 30 mm in the machine direction and 25 mm in the cross direction allow the bandage to follow joint curvature without lifting at the edges. Elastic nonwoven materials in the 20–60 g/m² basis weight range consistently achieve these values, especially when the manufacturing process orients fiber bundles randomly rather than unidirectionally.
A second flexibility parameter worth verifying is drape coefficient, measured by optical projection methods. This captures the material's three-dimensional draping behavior rather than single-axis bending. For bandage substrates, a drape coefficient below 0.5 correlates with good clinical wear performance.
Material Specification Checklist for Bandage Buyers
When comparing elastic nonwoven substrates for medical bandage programs, the following property set should be requested with method documentation:
| Property | Target Range | Relevance |
|---|---|---|
| Basis weight | 20–60 g/m² | Thinner substrates perform better on curved surfaces |
| MD/CD elongation at break | ≥200% both directions | Enables multi-directional conformance to skin |
| Permanent set after 5 cycles | ≤5% | Prevents sag after repeated joint movement |
| Elastic recovery | ≥95% after 5 cycles | Maintains secure hold throughout wear |
| Bending length | ≤30 mm MD / ≤25 mm CD | Ensures conformity to small-radius joints |
| MVTR | ≥800 g/m²/24h | Prevents maceration under occlusive bandages |
| Thickness | <0.2 mm | Low profile reduces edge lift and patient discomfort |
| Static COF vs. skin analog | ≥0.4 | Positional stability without relying on adhesive alone |
MVTR is measured per ASTM E96 or JIS L 1099; verify consistent method across supplier comparisons. For bandages worn continuously for 24 hours or more, MVTR values above 800 g/m²/24h are considered the threshold for preventing skin maceration. Elastic nonwoven constructions with microporous film technology achieve this while maintaining the moisture barrier that protects the wound bed.
Supplier Capability Assessment for Medical Bandage Programs
- Cleanroom production. Bandages applied to open or post-surgical wounds require substrates manufactured in a controlled environment. Verify the classification level and whether the facility maintains documented environmental monitoring.
- Biocompatibility documentation. ISO 10993-5 (cytotoxicity) and ISO 10993-10 (irritation and sensitization) are the minimum for skin-contact bandages. For products with prolonged contact time, ISO 10993-18 chemical characterization data becomes relevant.
- Regulatory compliance. FDA registration, RoHS compliance, and REACH certification are baseline requirements for materials entering regulated healthcare markets. Verify the scope and currency of each certification.
- Width tolerance and slitting. Bandage convertors typically run narrow-width rolls (50–150 mm). Ask for slit width tolerance — within ±0.5 mm — and evidence of clean cut edges without fiber debris.
- Process compatibility. The substrate must survive adhesive coating, lamination to absorbent pads, and sterilization. EtO and gamma sterilization are most common for bandages; the material should show less than 10% change in mechanical properties after exposure to the sterilization method used in manufacturing.
- Lot-level traceability. Medical device regulations require traceability from finished product back to raw material lot. Suppliers should maintain batch records linking production lots to raw material sources, process parameters, and quality release data.
Chambroad Elastic Nonwoven Grades for Medical Bandage Applications
Chambroad's KNE-AP70 is a medical-grade breathable elastic membrane substrate designed for wound dressings and medical fixation products. It provides multi-directional stretch with elongation above 270%, elastic recovery above 95% after repeated cycling, and a moisture vapor transmission rate above 800 g/m²/24h. The construction, under 0.2 mm in thickness, combines low bending stiffness with a microporous structure that supports both breathability and moisture barrier function. The product has passed biocompatibility verification and holds FDA registration, RoHS, and REACH compliance.
For bandage programs requiring dynamic conformability — such as joint dressings, fixation tapes, and post-surgical wound covers — the KNE-AP/FM series offers a four-direction elastic fiber stack structure with elastic recovery above 95%. It is supported by three authorized patents for microporous technology and carries RoHS, REACH, and FDA certifications. The low elastic modulus design reduces skin compression during extended wear, addressing the patient comfort dimension alongside mechanical performance.
For broader context on how elastic nonwoven materials are reshaping textile applications across hygiene, medical, and cosmetic segments, refer to the TPU elastic non-woven overview on the Chambroad solutions site.
Medical Bandage Substrate — Material Inquiry
Chambroad supplies medical-grade elastic nonwoven substrates for bandage and wound care converters. Contact us with your target basis weight, width, and sterilization requirements for product recommendations.
Contact Us
